Stock market announcement archive

June 17, 2020
Christian Saure har vært styreleder i Lifecare AS siden mai 2016. Han har varslet selskapet om at han ikke tar gjenvalg på årets generalforsamling og fratrer etter eget ønske pr 26.06.2020. I den forbindelse har Sterna Holding AS, et selskap 100 % eid av Christian Saure som er primærinnsider i Lifecare AS, den 15.06 og […]
Read more
June 15, 2020
Lifecare’s partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test – plan for scaling capacities with production partners in USA and Europe and aim to bring test to the market in millions. The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has developed […]
Read more
June 2, 2020
Scientific breakthrough: Lifecare’s partner Digital Diagnostics AG detects corona virus with rapid test, seeks FDA approval and plans to deliver units starting in July The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has successfully detected SARS-CoV-2 viruses using the revolutionary Cantisense™ technology at the Helmholtz Centre for […]
Read more
April 23, 2020
Sterna Holding AS, et selskap 100 % eid av Christian Saure som er styreformann og primærinnsider i Lifecare AS LIFE-ME) har 21. april og 22. april solgt 1.115.000 aksjer i Lifecare AS til kurs 3,4179. Salget skyldes en rebalansering av Sterna Holding AS sin investeringsportefølje. Etter salget eier Sterna Holding AS 2.235.000 aksjer i Lifecare […]
Read more
April 1, 2020
The Board of Directors in Lifecare AS has extended the exercise period for: - 527.839 share options for Chief Operation Officer, Rune Frisvold; - 263.920 share options for Chief Scientific Officer, Andreas Pfützner, until April 1st, 2021. The options were issued December 2016 and has a strike price of NOK 0,40. This information is subject […]
Read more
February 26, 2020
At the 13th International Conference on Advanced Technology and Treatments for Diabetes (ATTD) in Madrid, a key event for global scientist, leading healthcare professionals and life science decision makers, Lifecare A/S (LIFE-ME) presented a poster on its advances in the development of the Sencell Continuous Glucose monitor. The poster with the title “Miniaturization of an […]
Read more
February 10, 2020
Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. 10.02.2020, Oslo Lifecare AS, a Norwegian life-science company, announced that they have filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. The purpose of this clinical pilot study is to explore the performance of the Sencell sensor technology […]
Read more
January 23, 2020
Finansiell kalender for Lifecare AS REGNSKAPSÅR 2019 01.06.2020 - Årsrapport REGNSKAPSÅR 2020 01.09.2020 - Halvårsrapport Årsrapport for 2019 med revidert regnskap og balanse fremlegges pr 01.06.20. Denne informasjonen offentliggjøres i henhold til kravene i Løpende forpliktelser.
Read more
January 20, 2020
Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development! Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory […]
Read more